Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)

Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii2-9. doi: 10.1136/ard.62.suppl_2.ii2.

Authors

D E Furst¹, F C Breedveld, J R Kalden, J S Smolen, G R Burmester, M Dougados, P Emery, A Gibofsky, A F Kavanaugh, E C Keystone, L Klareskog, A S Russell, L B A van de Putte, M H Weisman

Affiliation

¹ University of California, UCLA, Rheumatology, Division Los Angeles, USA. defurst@mednet.ucla.edu

No abstract available

Publication types

Consensus Development Conference
Review

MeSH terms

Antirheumatic Agents / adverse effects
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Humans
Immunologic Factors / adverse effects
Immunologic Factors / therapeutic use*
Interleukin-1 / antagonists & inhibitors
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Antirheumatic Agents
Immunologic Factors
Interleukin-1
Tumor Necrosis Factor-alpha